Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 5, 2004 - Issue 1
Submit an article Journal homepage
55
Views
15
CrossRef citations to date
0
Altmetric
Review

The role of aspirin in cardiovascular diseases – forgotten benefits?

Adam Williams Cardiovascular Research Institute, Mount Sinai Medical Center – Miami Heart Institute, Miami, FL, USA. [email protected]
&
Charles H Hennekens Cardiovascular Research Institute, Mount Sinai Medical Center – Miami Heart Institute, Miami, FL, USA. [email protected]
Pages 109-115 | Published online: 02 Mar 2005

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Charles H Hennekens & Wendy R Schneider. (2008) The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease. Expert Review of Cardiovascular Therapy 6:1, pages 95-107.
Read now

Articles from other publishers (14)

Xiaolong Wu, Minghui Wei, Haifeng Zhang, Xiaomei Fan, Xiaochen Ma, Jiaming Liu & Mingming Xue. (2021) The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats. BioMed Research International 2021, pages 1-10.
Crossref
Pratibha Kamble, Dmitry Litvinov, Chandrakala Aluganti Narasimhulu, Xueting Jiang & Sampath Parthasarathy. (2015) Aspirin may influence cellular energy status. European Journal of Pharmacology 749, pages 12-19.
Crossref
Charles H. Hennekens & James E. Dalen. (2013) Aspirin in the Treatment and Prevention of Cardiovascular Disease: Past and Current Perspectives and Future Directions. The American Journal of Medicine 126:5, pages 373-378.
Crossref
Pratibha Kamble, Krithika Selvarajan, Chandrakala Aluganti Narasimhulu, Mukesh Nandave & Sampath Parthasarathy. (2013) Aspirin may promote mitochondrial biogenesis via the production of hydrogen peroxide and the induction of Sirtuin1/PGC-1α genes. European Journal of Pharmacology 699:1-3, pages 55-61.
Crossref
Iryna VoloshynaSyed M. HussainiAllison B. Reiss. (2012) Resveratrol in Cholesterol Metabolism and Atherosclerosis. Journal of Medicinal Food 15:9, pages 763-773.
Crossref
Joseph A. Baur. (2010) Biochemical effects of SIRT1 activators. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1804:8, pages 1626-1634.
Crossref
Charles H. Hennekens. (2007) Aspirin in the treatment and prevention of cardiovascular disease: Current perspectives and future directions. Current Atherosclerosis Reports 9:5, pages 409-416.
Crossref
Joseph A. Baur & David A. Sinclair. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews Drug Discovery 5:6, pages 493-506.
Crossref
Udaya S Tantry, Amena EtheringtonKevin P BlidenPaul A Gurbel. (2006) Antiplatelet therapy: current strategies and future trends. Future Cardiology 2:3, pages 343-366.
Crossref
David L. DeMets & Charles H. Hennekens. 2006. Data Monitoring in Clinical Trials. Data Monitoring in Clinical Trials 73 84 .
Victor L. Serebruany, Christopher M. O’Connor, Ranga R. Krishnan & Charles H. Hennekens. (2016) Hypothesis: Antiplatelet Effects of Selective Serotonin Reuptake Inhibitors Cause Clinical Benefits on Cardiovascular Disease and Increase Risks of Bleeding. Journal of Cardiovascular Pharmacology and Therapeutics 10:3, pages 163-164.
Crossref
Victor A. Ferraris, Suellen P. Ferraris, David J. Moliterno, Philip Camp, Jeanine M. Walenga, Harry L. Messmore, Walter P. Jeske, Fred H. Edwards, David Royston, David M. Shahian, Eric Peterson, Charles R. Bridges & George Despotis. (2005) The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and Other Antiplatelet Agents During Operative Coronary Revascularization (Executive Summary)*. The Annals of Thoracic Surgery 79:4, pages 1454-1461.
Crossref
Cornelia M. Ulrich, John Whitton, Joon-Ho Yu, Justin Sibert, Rachel Sparks, John D. Potter & Jeannette Bigler. (2005) PTGS2 ( COX-2 ) −765G > C Promoter Variant Reduces Risk of Colorectal Adenoma among Nonusers of Nonsteroidal Anti-inflammatory Drugs . Cancer Epidemiology, Biomarkers & Prevention 14:3, pages 616-619.
Crossref
Tobias Kurth, Charles H. Hennekens, Julie E. Buring & J. Michael Gaziano. (2004) Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: Possible interactions and implications for treatment of rheumatoid arthritis. Current Rheumatology Reports 6:5, pages 351-356.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.